Supply Chains for Cell & Gene Therapies: Orchestrating a successful Launch & Beyond.
Advanced Therapy Medicinal Products (ATMPs), also known as cell and gene therapies, are becoming increasingly common. However, they’re far more complex than “traditional” biotech products, with sophisticated requirements throughout their supply chains.
Join us on October 20th at 10am ET for an in-depth review of the sophisticated requirements for cell and gene therapy supply chains.
Add this webinar to your Calendar